It is of interest to note that 75.8% ±7.5%of the applied 125I-EPO is in the brain after only 60 minutes.
A Mann-Whitney U test was applied to compare variables in EPO-d mice with those in control mice variables.
To simulate the molecular adaptation of omptins, we applied site-specific mutagenesis to make Epo of the plant pathogenic Erwinia pyrifoliae exhibit virulence-associated functions of its close homolog, the plasminogen activator Pla of Yersinia pestis.
When linear regression analysis was applied to pre- and post-EPO 1/creatinine data the mean rate of decline was -0.0140 ± 0.0119 (mean ± SD) and -0.0017 ± 0.0090 (non-parametric Wilcoxon matched pairs signed rank sum test: Z value: -2.91; P = 0.004) respectively.
When linear regression analysis was applied to pre- and post-EPO 1/creatinine data the mean rate of 1/creatinine decline was -0.0140 ± 0.0119 (mean ± SD) and -0.0017 ± 0.0090 (using the non-parametric Wilcoxon matched pairs signed rank sum test: Z statistical value of -2.91 which corresponds to a two tailed P = 0.004) respectively.
Scanning electron microscopy (SEM) was applied to observe the shape and size of the resulting EPO-PLGA microspheres.
However, when LY294002 was applied to the rats as in ET+EPO+ LY group, the ultrastructure abnormalities of renal cell were more pronounced than those in the rats of ET+EPO group, e.g. there were irregular microvilli in the podocytes, a large number of fibrosis and apoptotic changed cells in the tubule mesenchyme.
To extract the EPO Fc fusion protein from the column, 20 µL of 2× Laemmli buffer (125 mM Tris HCl, pH 6.8, 20% glycerin, 4% SDS; 10% mercaptoethanol, 0.1% bromphenol blue) was applied, incubated for 5 min at 95°C and centrifuged for 1 min (9000 × g).
This information is often referred to as "prior art". Schwegman prosecutes foreign patents as well, and Schwegman used one of the Articles, the Rabeau Article, in helping a client apply for patents from the Japan Patent Office ("JPO") and the European Patent Office ("EPO").
These results highlight the importance of applying a minimum period (4 weeks) of transient immunosuppression if the host acceptance of xenogeneic implants based on microencapsulated Epo-secreting cells is aimed.
